Ilaris (canakinumab) is a prescription drug that’s used to treat certain conditions such as Still disease. Ilaris comes as a liquid solution that a healthcare professional will give as an injection ...

Ilaris (canakinumab) can cause side effects that range from mild to serious. More common side effects include weight gain and the common cold. If side effects from Ilaris become difficult to tolerate, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Novartis’ Ilaris injection for the treatment of active and adult-onset Still’s disease, ...

A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA). Zepzelca handed accelerated approval for metastatic SCLC in adults Jazz Pharmaceuticals and ...

Jul 28, 2009 -- Swiss pharmaceutical group Novartis has reported that the EU's Committee on Human Medicinal Products has issued a positive opinion recommending the approval of Ilaris for ...

The approval of Ilaris (canakinumab) in the treatment of adult-onset Still's disease (AOSD) brings hope for Canadians living with this rare, debilitating, and sometimes life-threatening inflammatory ...

ZURICH, May 10 (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis. Ilaris inhibits ...

Stocks limped to the end of the week on Friday, the dollar was set for its worst week in a month while gold flirted with a record peak as investors feared U.S. President Donald Trump's sweeping ...